ZYUS

ZYUS (TSXV: ZYUS) is a life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates for pain management. Through rigorous scientific exploration and clinical research, ZYUS aims to secure intellectual property protection, safeguarding its innovative therapies and bolstering shareholder value... ZYUS is primarily focused on the development, patent protection and regulatory approval of its drug product candidates through clinical trials. Simultaneously, ZYUS is committed to offering patients immediate access to its foundational products for compassionate reasons... ZYUS is inspired by science. Born from the abstraction of ‘science' and ‘zygote' (the fusion of two cells), we represent the beginning of life and the importance of improving quality of life. We believe in taking a forward, collaborative approach and place high value in our teamwork, partnerships and commitment to the broader ‘us' - society. We believe that..

Also known as: ZYUS Life Sciences, ZYUS Life Sciences Corp., ZYUS Life Sciences Corporation, ZYUS Life Sciences Inc.

Primary location: Saskatoon Canada